The usefulness of soluble ST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
| Image |  |
|---|---|
| Description | scientific article published on 14 June 2017 |
| Author/s | |
| Publication date | June 14, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |